Publication Name	World Journal of Translational Medicine
Manuscript ID	41374
Country	Greece

Received	2018-08-04 07:02
Peer-Review Started	2018-08-06 11:58
To Make the First Decision	2018-10-08 01:13
Return for Revision	2018-10-10 08:51
Revised	2019-01-09 12:25
Second Decision	2019-01-26 08:59
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2019-01-28 20:43
Articles in Press	2019-01-28 20:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-01-30 05:36
Publish the Manuscript Online	2019-01-30 07:18

ISSN	2220-6132 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Editorial
Article Title	Inflammation and cardiovascular disease
Manuscript Source	Invited Manuscript
All Author List	Christina G Katsiari, Dimitrios P Bogdanos and Lazaros I Sakkas
ORCID	Author(s) ORCID Number Christina G Katsiari http://orcid.org/0000-0002-4174-6576 Dimitrios P Bogdanos http://orcid.org/0000-0002-9697-7902 Lazaros I Sakkas http://orcid.org/0000-0002-7670-3314
Funding Agency and Grant Number
Corresponding Author	Lazaros I Sakkas, FRCP (Hon), MD, PhD, Professor, Department of Rheumatology and Clinical Immunology, Division of Medicine, University of Thessaly, Panepistimiou 1, Larissa 41110, Greece. lsakkas@med.uth.gr
Key Words	Cardiovascular disease; Coronary artery disease; Atherosclerosis; Inflammation; Innate immunity; Adaptive immunity; Biologic drugs
Core Tip	The association of inflammation with cardiovascular disease (CVD) has two aspects. The first is whether inflammation plays a pathogenic role in traditional risk factors-mediated CVD or it is just an epiphenomenon. The second is whether chronic inflammation caused by an inflammatory disease has any impact on CVD. Chronic inflammation exemplified by elevated high sensitivity C-reactive protein has been added for risk factors for CVD. How inflammation contributes to CVD is a topic of continuous research. A trial showing that anti-IL1b monoclonal-antibody reduced cardiovascular events is the best proof of the pathogenic contribution of inflammation in atherosclerosis and CVD.
Publish Date	2019-01-30 07:18
Citation	Katsiari CG, Bogdanos DP, Sakkas LI. Inflammation and cardiovascular disease. World J Translational Medicine 2019; 8(1): 1-8
URL	https://www.wjgnet.com/2220-6132/full/v8/i1/1.htm
DOI	https://dx.doi.org/10.5528/wjtm.v8.i1.1

Full Article (PDF)	WJTM-8-1.pdf
Full Article (Word)	WJTM-8-1.docx
Manuscript File	41374-Review.docx
Answering Reviewers	41374-Answering reviewers.pdf
Audio Core Tip	41374-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	41374-Conflict-of-interest statement.pdf
Copyright License Agreement	41374-Copyright license agreement.pdf
Peer-review Report	41374-Peer-review(s).pdf
Scientific Editor Work List	41374-Scientific editor work list.pdf